These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Efficacy and Safety of the Duodeno-Jejunal Bypass Liner in Patients With Metabolic Syndrome: A Multicenter Randomized Controlled Trial (ENDOMETAB). Caiazzo R; Branche J; Raverdy V; Czernichow S; Carette C; Robert M; Disse E; Barthet M; Cariou B; Msika S; Behal H; Denies F; Dervaux B; Duhamel A; Verkindt H; Pattou F Ann Surg; 2020 Nov; 272(5):696-702. PubMed ID: 32889869 [TBL] [Abstract][Full Text] [Related]
14. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus. Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690 [TBL] [Abstract][Full Text] [Related]
15. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients. Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558 [TBL] [Abstract][Full Text] [Related]
16. The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Yvamoto EY; de Moura DTH; Proença IM; do Monte Junior ES; Ribeiro IB; Ribas PHBV; Hemerly MC; de Oliveira VL; Sánchez-Luna SA; Bernardo WM; de Moura EGH Obes Surg; 2023 Feb; 33(2):585-599. PubMed ID: 36508156 [TBL] [Abstract][Full Text] [Related]
17. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity. Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090 [TBL] [Abstract][Full Text] [Related]
18. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids. Glaysher MA; Ward J; Aldhwayan M; Ruban A; Prechtl CG; Fisk HL; Chhina N; Al-Najim W; Smith C; Klimowska-Nassar N; Johnson N; Falaschetti E; Goldstone AP; Miras AD; Byrne JP; Calder PC; Teare JP Clin Nutr; 2021 Apr; 40(4):2343-2354. PubMed ID: 33131909 [TBL] [Abstract][Full Text] [Related]
19. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes. Jirapinyo P; Haas AV; Thompson CC Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis. Chen W; Feng J; Dong S; Guo J; Zhou F; Hu S; Hu R; Wang C; Ma Y; Dong Z Obes Rev; 2024 Nov; 25(11):e13812. PubMed ID: 39191438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]